leisure time -WSS

leisure time

author：knowledge 2025-09-28 23:49:11 - browse：95

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Alexander Hamilton and the argument for universal insurance

WSS

President Biden's budget: Here's what you might have missed

Hospitals, health systems can help patients avoid medical debt

EPA limits use of carcinogenic gas for sterilizing medical devices

John Green on his newest strategy for fighting tuberculosis

Medicare coverage of Wegovy, once blocked, now looks possible

Steward Health Care Massachusetts hospitals face fiscal disaster

hotspot

leisure time

hotspot

How to save PrEP access — and even expand it

Why scientists need input from humanists on sensitive research

After affirmative action ruling, medical educators look to 'holistic review'

Marc Tessier

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Male and female sex labels in research insufficient, scientists say

23andMe had bad news about my health. I wish a person had delivered it

Steward Health Care Massachusetts hospitals face fiscal disaster

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Marc Tessier

leisure time

Why scientists need input from humanists on sensitive research

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Public health communication lessons from Covid

Ebola: Gilead Sciences antiviral shows promise as new treatment

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Readout Newsletter: Bristol, Sangamo, Gilead, and more

entertainment

focus

knowledge

focus